Data / Research funding / Washington / Fred Hutchinson Cancer Research Center

Fred Hutchinson Cancer Research Center: 258 NIH awards ($454.1M), fiscal years 2021 to 2026

Name: NIH and NSF awards to Fred Hutchinson Cancer Research Center
Creator: SpecStream
License: https://creativecommons.org/licenses/by/4.0/

Fred Hutchinson Cancer Research Center in Seattle, WA is funded under 258 NIH awards ($454.1M) in the NIH and NSF award files, read 2026-11-04. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.

SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.

Get awards like these Watch Fred Hutchinson Cancer Research Center

NIH institution profile: 861001
State: Washington
Note: NIH gives no UEI for this institution, so NSF awards are not matched.

Awards

258 awards in the window.

Award	Agency	Institute or division	Fiscal year	Amount in window	Start	End	Principal investigator	Source
CoVPN LOC Cross-Protocol Infrastructure Supplement for GY15 and GY16	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2022	$156,469,927	March 30, 2022	March 31, 2022	COREY, LAWRENCE	reporter.nih.gov
CoVPN 5001 - A prospective study of acute immune responses to SARS-CoV-2 infection	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2022	$57,987,348	March 21, 2022	March 31, 2022	GILBERT, PETER B.	reporter.nih.gov
HVTN 405/HPTN 1901 (CoVPN) Characterizing SARS-CoV-2-specific Immunity in Convalescent Individuals: LC 3	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2022	$54,331,950	March 18, 2022	March 31, 2022	MCELRATH, MARGARET JULIANA	reporter.nih.gov
SDMC: HIV Prevention Trials Network	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2022	$23,565,144	June 29, 2006	March 31, 2022	DONNELL, DEBORAH J	reporter.nih.gov
Personal Protective Equipment for Resources for COVID-19 Related Vaccine and Treatment Clinical Trials and Clinical Studies	NIH	National Institute of Allergy and Infectious Diseases	2021	$21,360,749	November 5, 2020	March 31, 2022	COREY, LAWRENCE	reporter.nih.gov
WOMEN'S HEALTH INITIATIVE - CLINICAL COORDINATING CENTER: TASK AREA B - LONG LIFE STUDY VISIT 2 LIMITED HOME VISIT	NIH	National Heart, Lung, and Blood Institute	2021 to 2022	$15,096,788	March 4, 2022	March 3, 2024	ANDERSON, GARNET	reporter.nih.gov
Administrative Supplement for the NCI P30 CCSG to extend partnerships with comprehensive cancer control coalitions to study implementation of evidence-based cancer control interventions	NIH	National Cancer Institute	2021	$11,079,774	January 1, 1997	March 31, 2022	LYNCH, THOMAS JAMES	reporter.nih.gov
SWOG Statistics and Data Management Center	NIH	National Cancer Institute	2021	$9,287,458	April 17, 2014	March 31, 2022	LEBLANC, MICHAEL L.	reporter.nih.gov
SEER CORE INFRASTRUCTURE SUPPORT	NIH	National Cancer Institute	2021 to 2022	$8,731,753	May 1, 2018	April 30, 2023	SCHWARTZ, PHD, STEPHEN	reporter.nih.gov
Statistical and Data Management Center (SDMC): Microbicide Trials Network	NIH	National Institute of Allergy and Infectious Diseases	2021	$3,470,954	June 29, 2006	November 30, 2021	BROWN, ELIZABETH RENATA	reporter.nih.gov
Expansion and targeted maturation of germline HIV-1 bNAb-associated BCRs	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2022	$2,404,480	December 6, 2018	March 31, 2022	STAMATATOS, LEONIDAS	reporter.nih.gov
Seattle-Lausanne Clinical Trials Unit	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2022	$1,995,056	February 1, 2007	March 31, 2022	MCELRATH, MARGARET JULIANA	reporter.nih.gov
Fred Hutchinson Cancer Research Center Lung SPORE	NIH	National Cancer Institute	2021	$1,863,485	August 1, 2019	March 31, 2022	HOUGHTON, A MCGARRY	reporter.nih.gov
Cancer Immunotherapy Trials Network Central Operations and Statistical Center	NIH	National Cancer Institute	2021	$1,731,885	September 22, 2010	March 31, 2022	DAVIDSON, NANCY ELLEN	reporter.nih.gov
Adult Leukemia Research Center	NIH	National Cancer Institute	2021	$1,697,384	August 28, 1997	March 31, 2022	HILL, GEOFFREY ROGER	reporter.nih.gov
Uncovering diverse genotype-phenotype relationships in prostate cancer	NIH	National Cancer Institute	2021	$1,419,627	September 23, 2021	March 31, 2022	LEE, JOHN KYUNG	reporter.nih.gov
The Early Detection Research Network: Data Management and Coordinating Center	NIH	National Cancer Institute	2021	$1,333,448	April 14, 2000	March 31, 2022	FENG, ZIDING	reporter.nih.gov
Comprehensive profiling of SARS-CoV-2 antibody responses and escape pathways	NIH	National Institute of Allergy and Infectious Diseases	2021	$1,292,062	June 1, 2020	March 31, 2022	OVERBAUGH, JULIE M.	reporter.nih.gov
Polygenic Risk Scores for Diverse Populations - Bridging Research and Clinical Care	NIH	National Heart, Lung, and Blood Institute	2021	$1,245,107	August 20, 2020	March 14, 2022	KOOPERBERG, CHARLES L	reporter.nih.gov
Physical Activity to Improve CV Health in Older Women: A Pragmatic Trial	NIH	National Heart, Lung, and Blood Institute	2021	$1,119,500	September 15, 2020	March 31, 2022	KOOPERBERG, CHARLES L	reporter.nih.gov
Targeting a Novel Hematopoietic Stem Cell Population in Non-Human Primates for Effective and Sustained Gene Therapy	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2022	$1,096,475	November 10, 2017	March 31, 2022	KIEM, HANS-PETER	reporter.nih.gov
The Gut Microbiota and Graft versus Host Disease (GVHD)	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2022	$1,087,284	November 9, 2017	March 31, 2022	FREDRICKS, DAVID NEAL	reporter.nih.gov
The Pacific Northwest Prostate Cancer SPORE	NIH	National Cancer Institute	2021	$1,061,199	September 19, 2002	March 31, 2022	NELSON, PETER S	reporter.nih.gov
Mechanisms of treatment failure in chimeric antigen receptor T cell therapy	NIH	National Cancer Institute	2021	$1,032,791	February 1, 2019	March 31, 2022	TILL, BRIAN	reporter.nih.gov
Mechanisms of transcriptional regulation and transcription factor specificity	NIH	National Institute of General Medical Sciences	2021	$1,016,851	May 1, 2021	March 31, 2022	HAHN, STEVEN M	reporter.nih.gov
Molecular analysis of genetic recombination and DNA break repair	NIH	National Institute of General Medical Sciences	2021	$954,941	May 1, 2016	March 31, 2022	SMITH, GERALD R	reporter.nih.gov
Early and Reinfection in High Risk Women	NIH	Eunice Kennedy Shriver National Institute of Child Health & Human Development	2021	$929,397	September 15, 1995	March 31, 2022	OVERBAUGH, JULIE M.	reporter.nih.gov
Nongenotoxic conditioning for gene therapy and allogeneic transplantation in Fanconi anemia	NIH	National Heart, Lung, and Blood Institute	2021 to 2022	$891,269	December 20, 2019	March 31, 2022	KIEM, HANS-PETER	reporter.nih.gov
HIV-CRISPR: A novel approach to the comprehensive discovery of HIV latency factors	NIH	National Institute on Drug Abuse	2021	$880,000	April 15, 2020	March 31, 2022	EMERMAN, MICHAEL	reporter.nih.gov
Epigenomic profiling of complex tissues with single-cell CUT&RUN	NIH	National Human Genome Research Institute	2021 to 2022	$845,319	April 19, 2019	March 31, 2022	HENIKOFF, STEVEN	reporter.nih.gov
Tissue Regulatory T Cells in Mucosal Infection	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2022	$839,611	November 7, 2018	March 31, 2022	LUND, JENNIFER M	reporter.nih.gov
Proteogenomic studies aimed at understanding ovarian tumor responses to agents targeting the DNA damage response and translating this knowledge into clinical benefit	NIH	National Cancer Institute	2021	$811,229	June 1, 2017	March 31, 2022	PAULOVICH, AMANDA G	reporter.nih.gov
Multiplex base/prime editors for in vivo selection of modified HSPCs in hemoglobinopathy	NIH	National Heart, Lung, and Blood Institute	2021 to 2022	$810,459	January 17, 2017	March 31, 2022	KIEM, HANS-PETER	reporter.nih.gov
Colaboracion Evita: HPV-Related Cancer Prevention Partnership Center	NIH	National Cancer Institute	2021	$803,006	September 18, 2019	March 31, 2022	MADELEINE, MARGARET M	reporter.nih.gov
Engineering knotted peptide therapeutics for pediatric brain tumor patients	NIH	National Cancer Institute	2021	$789,957	January 12, 2018	December 31, 2021	OLSON, JAMES M	reporter.nih.gov
Membrane Curvature Sensing Mechanisms for Synaptic Vesicle Endocytosis	NIH	National Institute of Neurological Disorders and Stroke	2021 to 2022	$745,105	February 15, 2020	March 31, 2022	BAI, JIHONG	reporter.nih.gov
Hematopoietic Stem Cell And Cord Blood Transplantation	NIH	National Institute of Allergy and Infectious Diseases	2021	$743,524	September 30, 2005	March 31, 2022	PETERSDORF, EFFIE W	reporter.nih.gov
Coordinating Center for Population-based Research to Optimize Cancer Screening (PROSPR) (U24)	NIH	National Cancer Institute	2021	$743,093	April 15, 2018	March 31, 2022	LI, CHRISTOPHER I	reporter.nih.gov
Defining cellular states of quiescence in human brain tumors	NIH	National Institute of Neurological Disorders and Stroke	2021 to 2022	$736,884	February 15, 2021	March 31, 2022	PADDISON, PATRICK	reporter.nih.gov
Full Scale Randomized Trial of an Innovative Conversational Agent for Smoking Cessation	NIH	National Cancer Institute	2021	$730,398	April 1, 2020	March 31, 2022	BRICKER, JONATHAN B	reporter.nih.gov
Harnessing endogenous mechanisms of thymic regeneration toboost immune function in recipients of hematopoietic cell transplant	NIH	National Heart, Lung, and Blood Institute	2021 to 2022	$729,507	January 1, 2019	March 31, 2022	DUDAKOV, JARROD	reporter.nih.gov
An Academic-Industry Partnership to Advance Functional Genomics for Personalized Oncology.	NIH	National Cancer Institute	2021 to 2022	$727,631	December 12, 2017	March 31, 2022	KEMP, CHRISTOPHER J	reporter.nih.gov
Targeting Nrf2 for Cancer Chemoprevention	NIH	National Cancer Institute	2021	$725,661	July 1, 2018	March 31, 2022	KENSLER, THOMAS W	reporter.nih.gov
1/2 Ganciclovir to Prevent Reactivation of Cytomegalovirus in Patients with Acute Respiratory Failure and Sepsis	NIH	National Heart, Lung, and Blood Institute	2021	$713,484	September 16, 2020	March 31, 2022	BOECKH, MICHAEL J	reporter.nih.gov
Modeling Precision Interventions for Prostate Cancer Control	NIH	National Cancer Institute	2021	$698,320	September 10, 2020	March 31, 2022	ETZIONI, RUTH D	reporter.nih.gov
D4Z4 Coding Transcripts and FSHD	NIH	National Institute of Arthritis and Musculoskeletal and Skin Diseases	2021 to 2022	$696,022	September 1, 1998	March 31, 2022	TAPSCOTT, STEPHEN J	reporter.nih.gov
MECHANISMS UNDERLYING OLFACTORY EFFECTS ON APPETITE	NIH	National Institute on Deafness and Other Communication Disorders	2021	$680,215	March 15, 2018	March 31, 2022	BUCK, LINDA B	reporter.nih.gov
Preventing Relapse After Non-myeloablative Stem Cell Transplantation: The Final Challenge	NIH	National Cancer Institute	2021	$679,409	April 12, 1999	March 31, 2022	SANDMAIER, BRENDA MARIE	reporter.nih.gov
Humoral immunity after CAR-T cell therapy for B cell malignancies: The HICAR Study	NIH	National Cancer Institute	2021	$662,560	January 1, 2020	March 31, 2022	HILL, JOSHUA AIDEN	reporter.nih.gov
The role of antibodies in mother to child HIV transmission	NIH	National Institute of Allergy and Infectious Diseases	2021	$659,708	March 1, 2008	March 31, 2022	OVERBAUGH, JULIE M.	reporter.nih.gov
Extrinsic regulation of primitive, myeloid-biased hematopoietic stem cells by Semaphorin 4a	NIH	National Heart, Lung, and Blood Institute	2021 to 2022	$657,206	January 1, 2021	March 31, 2022	SILBERSTEIN, LEV	reporter.nih.gov
Integrative Genomics into Genetic Association Studies of Blood Pressure and Stroke in African Americans	NIH	National Heart, Lung, and Blood Institute	2021	$653,673	March 15, 2021	March 31, 2022	HSU, LI	reporter.nih.gov
PCPT and SELECT Cohorts: Core Infrastructure Support for Cancer Research	NIH	National Cancer Institute	2021	$653,163	September 20, 2013	March 31, 2022	TANGEN, CATHERINE M.	reporter.nih.gov
Nutrition and Physical Activity Assessment Study - Assessment of Dietary Supplements	NIH	National Cancer Institute	2021	$640,117	March 8, 2021	June 30, 2021	NEUHOUSER, MARIAN L	reporter.nih.gov
Prostate cancer Active Surveillance Study (PASS) Cohort: Infrastructure Support for Cancer Research	NIH	National Cancer Institute	2021	$639,455	September 20, 2019	March 31, 2022	LIN, DANIEL W.	reporter.nih.gov
ODOR BLOCKING OF STRESS	NIH	National Institute on Deafness and Other Communication Disorders	2021	$630,324	March 1, 2018	March 31, 2022	BUCK, LINDA B	reporter.nih.gov
Addressing Cancer-Related Financial Hardship through Delivery of a Proactive Financial Navigation Intervention	NIH	National Cancer Institute	2021	$626,428	April 16, 2020	March 31, 2022	SHANKARAN, VEENA	reporter.nih.gov
Molecular mechanisms and functions of global chromatin control	NIH	National Institute of General Medical Sciences	2021 to 2022	$616,481	January 1, 2021	March 31, 2022	TSUKIYAMA, TOSHIO	reporter.nih.gov
Genetic requirements of Helicobacter pylori infection	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2022	$605,148	December 1, 2003	March 31, 2022	SALAMA, NINA	reporter.nih.gov
Stopping PDA progression using inhibitors of CSC dissemination and immunotherapy	NIH	National Cancer Institute	2021	$595,859	March 17, 2021	August 31, 2021	HINGORANI, SUNIL R	reporter.nih.gov
Infrastructure Support and Pilot Tissue Collection for the CARET Biorepository	NIH	National Cancer Institute	2021	$592,642	April 1, 2013	March 31, 2022	CHEN, CHU	reporter.nih.gov
Hormone signaling and translation control in advanced prostate cancer	NIH	National Cancer Institute	2021 to 2022	$584,722	December 6, 2018	March 31, 2022	HSIEH, ANDREW CALEB	reporter.nih.gov
Tumor-specific autoantibodies for SCLC early detection	NIH	National Cancer Institute	2021 to 2022	$581,523	December 17, 2019	March 31, 2022	HOUGHTON, A MCGARRY	reporter.nih.gov
Complete mapping of immune selection from antibodies to HIV	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2022	$581,480	December 7, 2018	March 31, 2022	BLOOM, JESSE D	reporter.nih.gov
The MYC Transcription Factor Network and the Path to Cancer	NIH	National Cancer Institute	2021	$576,145	September 1, 2018	March 31, 2022	EISENMAN, ROBERT NEIL	reporter.nih.gov
Harnessing Tissue Resident Memory T Cells for Immunotherapy of Herpes Virus Infections	NIH	National Institute of Allergy and Infectious Diseases	2021	$564,908	June 13, 2018	March 31, 2022	COREY, LAWRENCE	reporter.nih.gov
Preventing GVHD by inhibition of alloantigen presentation in the gut	NIH	National Heart, Lung, and Blood Institute	2021	$562,863	July 1, 2019	March 31, 2022	HILL, GEOFFREY ROGER	reporter.nih.gov
Mathematical modeling of optimal therapeutic combinations for HIV cure	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2022	$561,399	December 16, 2019	March 31, 2022	CARDOZO OJEDA, ERWING FABIAN	reporter.nih.gov
Origin firing at repetitive sequences and genome replication	NIH	National Institute of General Medical Sciences	2021	$553,339	February 1, 2016	March 31, 2022	BEDALOV, ANTONIO	reporter.nih.gov
Investigating How Cellular Mechanisms Interface To Maintain Energy Balance	NIH	National Institute of General Medical Sciences	2021	$545,487	September 11, 2017	July 31, 2022	RAJAN, AKHILA	reporter.nih.gov
Role of tumor cell cluster-induced signaling in breast cancer metastasis	NIH	National Cancer Institute	2021 to 2022	$544,611	December 1, 2019	March 31, 2022	CHEUNG, KEVIN JON	reporter.nih.gov
Regulation of cell migration and signaling by phosphotyrosine and ubiquitin	NIH	National Institute of General Medical Sciences	2021 to 2022	$523,992	August 1, 2014	March 31, 2022	COOPER, JONATHAN A	reporter.nih.gov
Chemotherapy-driven evolution of the vascular secretome and its role in therapeutic resistance	NIH	National Cancer Institute	2021 to 2022	$523,403	January 1, 2021	March 31, 2022	GHAJAR, CYRUS M	reporter.nih.gov
Human Papillomavirus and Polyomavirus Associated Malignancies.	NIH	National Cancer Institute	2021	$521,176	September 15, 2017	March 31, 2022	GALLOWAY, DENISE A.	reporter.nih.gov
Targeting macrophages in metastatic cancer	NIH	National Cancer Institute	2021 to 2022	$520,525	February 7, 2019	March 31, 2022	RONGVAUX, ANTHONY	reporter.nih.gov
Genetic and molecular basis for SRSF2 mutations in myelodysplasia	NIH	National Heart, Lung, and Blood Institute	2021	$519,636	August 1, 2015	March 31, 2022	BRADLEY, ROBERT K	reporter.nih.gov
Employing CRISPR inactivation screening and in vivo models towards improving treatments for SCLC	NIH	National Cancer Institute	2021	$516,606	March 8, 2019	March 31, 2022	MACPHERSON, DAVID	reporter.nih.gov
Developing Bioinformatic and Microfluidic Single Cell Methods for Studying Intratumoral Heterogeneity in Acute Myeloid Leukemia	NIH	National Cancer Institute	2021 to 2022	$511,882	December 10, 2018	March 31, 2022	PAGUIRIGAN, AMY	reporter.nih.gov
Hutchinson Center as Lead Academic Participating Site (UG1)	NIH	National Cancer Institute	2021	$495,580	March 6, 2019	March 31, 2022	YU, EVAN	reporter.nih.gov
(PQ6) Radiogenomics of colorectal polyps to assess benign proliferative vs. premalignant states.	NIH	National Cancer Institute	2021	$491,493	September 21, 2017	March 31, 2022	GRADY, WILLIAM MALLORY	reporter.nih.gov
Diversity Supplement to Targeted Therapy in Ex Vivo Medulloblastoma/PNET	NIH	National Cancer Institute	2021	$490,546	July 1, 2021	December 31, 2021	OLSON, JAMES M	reporter.nih.gov
Combined computational and structural studies to create novel macromolecular recognition properties	NIH	National Institute of General Medical Sciences	2021 to 2022	$489,108	April 1, 2021	March 31, 2022	STODDARD, BARRY L.	reporter.nih.gov
The role and mechanism of alternative RNA splice variants and gene fusions as drivers of cancer	NIH	National Cancer Institute	2021	$485,162	September 21, 2021	March 31, 2022	HOLLAND, ERIC C.	reporter.nih.gov
Radioimmunotherapy Combinations for B-cell Malignancy	NIH	National Cancer Institute	2021 to 2022	$484,621	January 1, 1998	March 31, 2022	GREEN, DAMIAN J.	reporter.nih.gov
Maternal-infant Virome Transmission: the role of HIV and Antiretroviral Therapy	NIH	Eunice Kennedy Shriver National Institute of Child Health & Human Development	2021	$478,048	September 6, 2017	March 31, 2022	LEHMAN, DARA ANN	reporter.nih.gov
Investigating chromatin mechanisms using viral systems	NIH	National Institute of General Medical Sciences	2021 to 2022	$473,521	September 1, 2019	March 31, 2022	AVGOUSTI, DAPHNE CHRISTINA	reporter.nih.gov
Personalized cancer models to discover and develop new therapeutic targets.	NIH	National Cancer Institute	2021	$470,312	September 14, 2017	March 31, 2022	KEMP, CHRISTOPHER J	reporter.nih.gov
Understanding and exploiting novel therapeutic vulnerabilities of RIT1-driven lung cancer	NIH	National Cancer Institute	2021	$467,377	April 1, 2021	March 31, 2022	BERGER, ALICE	reporter.nih.gov
Functional and molecular basis of ineffective erythropoiesis in SF3B1-mutant myelodysplastic syndromes	NIH	National Heart, Lung, and Blood Institute	2021	$461,320	June 1, 2020	March 31, 2022	BRADLEY, ROBERT K	reporter.nih.gov
Statistical Methods for Large Scale Microbiome Studies of Cardiovascular Disease Risk	NIH	National Heart, Lung, and Blood Institute	2021	$460,006	March 15, 2021	March 31, 2022	WU, MICHAEL CHIAO-AN	reporter.nih.gov
2/2 Partnership for the Advancement of Cancer Research: NMSU & Fred Hutch	NIH	National Cancer Institute	2021	$458,198	September 30, 2007	March 31, 2022	SIMON, JULIAN	reporter.nih.gov
The role of the senescent microenvironment on cancer initiating cells in the colon.	NIH	National Institute on Aging	2021	$451,960	September 30, 2021	March 31, 2022	GRADY, WILLIAM MALLORY	reporter.nih.gov
Evolution and mechanisms of cytomegalovirus antagonism of host cell defenses	NIH	National Institute of Allergy and Infectious Diseases	2021	$443,857	April 1, 2020	March 31, 2022	GEBALLE, ADAM P.	reporter.nih.gov
Investigating CREBBP as a tumor suppressor in small cell lung cancer	NIH	National Cancer Institute	2021	$441,962	December 15, 2016	November 30, 2021	MACPHERSON, DAVID	reporter.nih.gov
Selective mRNA translation in developmental disorders	NIH	National Institute of General Medical Sciences	2021	$433,184	June 18, 2020	March 31, 2022	BERONJA, SLOBODAN	reporter.nih.gov
Defining the protective efficacy of antibodies against the EBV gH/gL glycoprotein complex	NIH	National Institute of Allergy and Infectious Diseases	2021	$432,778	August 9, 2019	March 31, 2022	MCGUIRE, ANDREW	reporter.nih.gov
MegaTALS: hyperspecific reagents for targeted gene modification and correction	NIH	National Institute of General Medical Sciences	2021 to 2022	$427,286	February 1, 2014	March 31, 2022	STODDARD, BARRY L.	reporter.nih.gov
Stem Cell and Transplantation Biology	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021	$424,832	August 1, 2015	March 31, 2022	TOROK-STORB, BEVERLY J.	reporter.nih.gov
Defining novel genetic dependencies in spliceosome mutant leukemia	NIH	National Cancer Institute	2021 to 2022	$420,503	December 1, 2019	March 31, 2022	LEE, STANLEY CHUN-WEI	reporter.nih.gov
Breast, Colorectal, and Ovary Cancer Clinical Validation Center	NIH	National Cancer Institute	2021	$418,953	August 16, 2010	March 31, 2022	LI, CHRISTOPHER I	reporter.nih.gov
Defining and Targeting Lineage Transition Programs Operative in AR Pathway Independent Prostate Cancer	NIH	National Cancer Institute	2021	$408,336	August 15, 2020	March 31, 2022	NELSON, PETER S	reporter.nih.gov
Investigating Max as a tumor suppressor gene in small cell lung cancer and other neuroendocrine tumors	NIH	National Cancer Institute	2021	$407,812	May 1, 2020	March 31, 2022	EISENMAN, ROBERT NEIL	reporter.nih.gov
Translational Research Program in Colorectal Cancer Disparities	NIH	National Cancer Institute	2021	$406,634	September 1, 2020	March 31, 2022	PETERS, ULRIKE	reporter.nih.gov
Exploring novel SRC-regulated pathways in IDH mutant intrahepatic cholangiocarcinoma	NIH	National Cancer Institute	2021	$402,600	April 1, 2021	March 31, 2022	KUGEL, SITA	reporter.nih.gov
Regulation of Protein Synthesis by Synonymous Codon Usage	NIH	National Institute of General Medical Sciences	2021	$400,101	September 9, 2016	March 31, 2022	SUBRAMANIAM, ARVIND RASI	reporter.nih.gov
Clonal hematopoiesis in the Women's Health Initiative	NIH	National Heart, Lung, and Blood Institute	2021	$394,927	July 15, 2019	March 31, 2022	REINER, ALEXANDER P	reporter.nih.gov
Consortium on Translational Research in Early Detection of Liver Cancer: Data Management and Coordinating Center (DMCC)	NIH	National Cancer Institute	2021	$389,953	September 17, 2018	March 31, 2022	FENG, ZIDING	reporter.nih.gov
Immuno and Epigenetics of Hematopoietic Cell Transplantation	NIH	National Cancer Institute	2021	$387,519	August 1, 2017	March 31, 2022	PETERSDORF, EFFIE W	reporter.nih.gov
Novel Approaches to CD33-Directed Radioimmunotherapy	NIH	National Cancer Institute	2021 to 2022	$384,853	December 15, 2019	March 31, 2022	WALTER, ROLAND BRUNO	reporter.nih.gov
ReCAPSE: Recurrence from Claims And PROs for SEER Enhancement	NIH	National Cancer Institute	2021	$380,204	September 25, 2017	March 31, 2022	ETZIONI, RUTH D	reporter.nih.gov
Epitranscriptomic control of erythropoiesis	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021	$377,360	September 17, 2019	March 31, 2022	PADDISON, PATRICK	reporter.nih.gov
The roles of EBV-specific T cells in response to checkpoint blockade immunotherapy of EBV-driven nasopharyngeal carcinoma	NIH	National Cancer Institute	2021	$355,610	August 1, 2021	March 31, 2022	NEWELL, EVAN	reporter.nih.gov
Statistical Methods for RNA-seq Data Analysis	NIH	National Institute of General Medical Sciences	2021	$349,264	May 15, 2014	March 31, 2022	SUN, WEI	reporter.nih.gov
Metabolic Constraints on Cancer Cell Proliferation	NIH	National Cancer Institute	2021	$347,543	December 1, 2018	November 30, 2021	SULLIVAN, LUCAS BRYAN	reporter.nih.gov
Niche signals in HSC genesis	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021	$340,657	September 1, 2017	March 31, 2022	BERNSTEIN, IRWIN D	reporter.nih.gov
Basal Cell Polarity Proteins in Normal Tissue Homeostasis and Cancer	NIH	National Cancer Institute	2021	$340,199	June 7, 2019	March 31, 2022	VASIOUKHIN, VALERI	reporter.nih.gov
Mechanisms of Tumor Derived Neutrophil Induced Apoptosis in Lymphocytes	NIH	National Cancer Institute	2021	$330,964	July 17, 2018	March 31, 2022	HOUGHTON, A MCGARRY	reporter.nih.gov
Exploring the epigenetic control of pancreatic cancer subtypes	NIH	National Cancer Institute	2021	$323,537	July 1, 2019	March 31, 2022	KUGEL, SITA	reporter.nih.gov
Defining and characterizing microenvironmental drivers of disseminated tumor cell dormancy in brain	NIH	National Cancer Institute	2021	$323,315	May 5, 2020	March 31, 2022	GHAJAR, CYRUS M	reporter.nih.gov
Quit2Heal: Rigorous Randomized Trial of a Smartphone Application to Help Cancer Patients Stop Smoking	NIH	National Cancer Institute	2021	$322,498	June 1, 2020	March 31, 2022	BRICKER, JONATHAN B	reporter.nih.gov
Fast and flexible Bayesian phylogenetics via modern machine learning	NIH	National Institute of Allergy and Infectious Diseases	2021	$321,306	July 1, 2021	March 31, 2022	MATSEN, FREDERICK ALBERT	reporter.nih.gov
Improving cancer survivorship care delivery in Latino survivors: telehealth & lay health educators	NIH	National Cancer Institute	2021	$315,575	September 21, 2021	March 31, 2022	CHOW, ERIC JESSEN	reporter.nih.gov
Cost of Cancer Supplement	NIH	National Cancer Institute	2021	$313,705	September 3, 2018	March 31, 2022	SORROR, MOHAMED	reporter.nih.gov
Roles and regulation of polyamines during HCMV infection	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2022	$313,114	December 1, 2020	March 31, 2022	GEBALLE, ADAM P.	reporter.nih.gov
Building independent research leaders in HIV-associated malignancies in Uganda	NIH	Fogarty International Center	2021	$299,988	June 1, 2014	March 31, 2022	PHIPPS, WARREN	reporter.nih.gov
Immunogenetics of Outcomes Disparities after Allogeneic HCT	NIH	National Cancer Institute	2021	$293,484	July 1, 2018	March 31, 2022	PETERSDORF, EFFIE W	reporter.nih.gov
Endonuclease-mediated disruption of latent HSV as curative therapy	NIH	National Institute of Allergy and Infectious Diseases	2021	$282,779	June 12, 2018	March 31, 2022	JEROME, KEITH R	reporter.nih.gov
Biologic correlatives of chronic GVHD onset	NIH	National Cancer Institute	2021	$279,864	July 2, 2019	March 31, 2022	LEE, STEPHANIE J	reporter.nih.gov
Inflammation-driven T Cell Responses and their Dichotomous Effect on Host Immunity	NIH	National Institute of Allergy and Infectious Diseases	2021	$273,212	December 1, 2016	March 31, 2022	PRLIC, MARTIN	reporter.nih.gov
Mechanisms regulating nuclear envelope structure and stability	NIH	National Institute of General Medical Sciences	2021	$272,348	August 1, 2017	March 31, 2022	HATCH, EMILY M	reporter.nih.gov
In Vivo Gene Editing of B cells with NICE-AAV Vectors	NIH	National Institute of Allergy and Infectious Diseases	2022	$271,147	December 16, 2021	March 31, 2022	PETERSON, CHRISTOPHER W	reporter.nih.gov
Structure-Based Designs of HIV-1 Immunogens Targeting Germline Precursors of Broadly Neutralizing Antibodies	NIH	National Institute of Allergy and Infectious Diseases	2021	$264,000	March 17, 2021	March 31, 2022	PANCERA, MARIE	reporter.nih.gov
Molecular and Cellular Mechanisms of Wound Repair	NIH	National Institute of General Medical Sciences	2021	$263,624	May 1, 2015	March 31, 2022	PARKHURST, SUSAN M	reporter.nih.gov
Regulation of Proteasome Capacity	NIH	National Institute of General Medical Sciences	2021	$262,872	August 3, 2021	March 31, 2022	LEHRBACH, NICOLAS JOHN	reporter.nih.gov
SMCHD1 Pathways as Candidate Targets for FSHD	NIH	National Institute of Arthritis and Musculoskeletal and Skin Diseases	2021	$261,057	April 25, 2014	March 31, 2022	TAPSCOTT, STEPHEN J	reporter.nih.gov
Liquid biopsy of the lung to profile lung cancer	NIH	National Cancer Institute	2021	$259,026	September 15, 2020	March 31, 2022	NAIR, VISWAM SIVA	reporter.nih.gov
Investigating the metastatic drive in pancreas cancer	NIH	National Cancer Institute	2021	$258,637	August 9, 2018	March 31, 2022	HINGORANI, SUNIL R	reporter.nih.gov
Generating rapid antitumor immunity with lymphocyte-reprogramming nanocarriers	NIH	National Cancer Institute	2021	$253,224	July 1, 2017	March 31, 2022	STEPHAN, MATTHIAS	reporter.nih.gov
Joint Modeling of Longitudinal Physical Activity and Diet Data and Survival	NIH	National Cancer Institute	2021	$251,098	February 6, 2020	January 31, 2022	WANG, CHING-YUN	reporter.nih.gov
Statistical Methods for Efficacy Trials of Vaccines and Monoclonal Antibodies Against Genetically-Diverse Pathogens	NIH	National Institute of Allergy and Infectious Diseases	2021	$248,674	April 1, 2003	March 31, 2022	GILBERT, PETER B.	reporter.nih.gov
2/2 Ganciclovir to Prevent Reactivation of Cytomegalovirus in Patients with Acute Respiratory Failure and Sepsis	NIH	National Heart, Lung, and Blood Institute	2021	$243,200	September 16, 2020	March 31, 2022	HUANG, YING	reporter.nih.gov
Delineating the mechanisms and clinical utility of mtDNA mutagenesis in cancer	NIH	National Cancer Institute	2021	$241,301	February 15, 2017	March 31, 2022	HOCKENBERY, DAVID M.	reporter.nih.gov
Improving treatment of cardiovascular risk factors in childhood cancer survivors	NIH	National Cancer Institute	2021	$241,294	March 1, 2017	March 31, 2022	CHOW, ERIC JESSEN	reporter.nih.gov
Pediatric Oncology Research Training Program	NIH	National Cancer Institute	2021	$233,745	August 1, 1979	March 31, 2022	BERNSTEIN, IRWIN D	reporter.nih.gov
Planning Advance Care Together (PACT) to Improve Engagement in Advance Care Planning among Advanced Cancer Patients	NIH	National Cancer Institute	2021	$230,184	September 8, 2020	March 31, 2022	SHEN, MEGAN JOHNSON	reporter.nih.gov
Clinical Significance of MHC Haplotypes in HCT	NIH	National Cancer Institute	2021	$227,652	March 1, 2003	March 31, 2022	PETERSDORF, EFFIE W	reporter.nih.gov
Therapeutic use of HPV L1 Vaccine in Anogenital Neoplasia: VIVA Trial	NIH	National Cancer Institute	2021	$227,161	February 22, 2017	March 31, 2022	MADELEINE, MARGARET M	reporter.nih.gov
Differentiation balances oncogene-driven proliferation to maintain epidermal homeostasis	NIH	National Institute of Arthritis and Musculoskeletal and Skin Diseases	2021	$224,790	July 27, 2017	March 31, 2022	BERONJA, SLOBODAN	reporter.nih.gov
Statistical Genetics and Genomics for Epidemiologic Research	NIH	National Cancer Institute	2021	$220,012	July 17, 2018	March 31, 2022	DAI, JAMES	reporter.nih.gov
Statistical Methods for Analysis of Tumor Heterogeneity in Genetic Epidemiology	NIH	National Cancer Institute	2021	$218,775	July 1, 2015	March 31, 2022	HSU, LI	reporter.nih.gov
(PQ5) Effect of HIV infection on viral and host gene expression and antitumor immunity in Kaposi Sarcoma in Africa	NIH	National Cancer Institute	2021	$218,186	May 11, 2017	March 31, 2022	WARREN, EDUS HOUSTON	reporter.nih.gov
SALSA - Study of Active Lifestyle Activation	NIH	National Cancer Institute	2021	$217,015	September 21, 2021	March 31, 2022	CHOW, ERIC JESSEN	reporter.nih.gov
Molecular Mechanisms That Control the Quality of Synaptic Vesicle Recycling	NIH	National Institute of General Medical Sciences	2021	$214,186	July 1, 2018	March 31, 2022	BAI, JIHONG	reporter.nih.gov
Molecular dissection of glia-neuron interactions	NIH	National Institute of Neurological Disorders and Stroke	2021	$213,708	September 30, 2020	March 31, 2022	SINGHVI, AAKANKSHA	reporter.nih.gov
Cellular mechanisms of nucleocytoplasmic export through Nuclear Envelope Budding	NIH	National Institute of General Medical Sciences	2021	$210,590	August 3, 2021	March 31, 2022	PARKHURST, SUSAN M	reporter.nih.gov
Topographic mapping by cranial motor neurons	NIH	National Institute of Neurological Disorders and Stroke	2021	$207,775	September 30, 2018	March 31, 2022	MOENS, CECILIA B	reporter.nih.gov
The role of Fusobacterium in colorectal cancer treatment, tumor ecology and chemotherapeutic efficacy	NIH	National Cancer Institute	2021	$204,273	August 1, 2019	March 31, 2022	BULLMAN, SUSAN	reporter.nih.gov
Real-time tracking of virus evolution for vaccine strain selection and epidemiological investigation	NIH	National Institute of General Medical Sciences	2021	$203,611	August 23, 2016	March 31, 2022	BEDFORD, TREVOR BC	reporter.nih.gov
Improving Outcomes Assessment in Chronic Graft versus Host Disease	NIH	National Cancer Institute	2021	$202,856	July 18, 2007	March 31, 2022	LEE, STEPHANIE J	reporter.nih.gov
Evaluation of commercially available prostate cancer assays to accelerate novel applications in active surveillance	NIH	National Cancer Institute	2021	$194,491	September 18, 2019	March 31, 2022	LIN, DANIEL W.	reporter.nih.gov
Therapeutic applications of CD4+ T cells specific for oncogenic driver mutations	NIH	National Cancer Institute	2021	$194,107	March 4, 2020	March 31, 2022	VEATCH, JOSHUA R	reporter.nih.gov
Identifying driver non-coding alterations in metastatic prostate cancer from tumor and cell-free DNA	NIH	National Cancer Institute	2021	$189,432	April 1, 2020	March 31, 2022	HA, GAVIN	reporter.nih.gov
HSV-2 specificity and phenotyping of tissue-based T cells in genital skin biopsies of HSV-2 reactivation	NIH	National Institute of Allergy and Infectious Diseases	2021	$189,272	February 1, 2020	March 31, 2022	FORD, EMILY	reporter.nih.gov
Frontiers in Cancer Research (SEPA Supplement)	NIH	National Institute of General Medical Sciences	2021	$188,621	August 1, 2018	June 30, 2023	CHOWNING, JEANNE TING	reporter.nih.gov
Development of an anti-idiotype based vaccine for respiratory syncytial virus	NIH	National Institute of Allergy and Infectious Diseases	2021	$188,029	June 1, 2021	March 31, 2022	MCGUIRE, ANDREW	reporter.nih.gov
A unique approach combining avatar mice and targeted mass spectrometry to identify blood biomarkers for early detection of breast cancer	NIH	National Cancer Institute	2021	$187,791	September 19, 2016	March 31, 2022	PAULOVICH, AMANDA G	reporter.nih.gov
Red and Processed Meat Effects on the Metabolome and Microbiome	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021	$185,917	May 21, 2021	March 31, 2022	NEUHOUSER, MARIAN L	reporter.nih.gov
Pathways to Cancer Research	NIH	National Cancer Institute	2021	$181,513	September 19, 2017	March 31, 2022	CHOWNING, JEANNE TING	reporter.nih.gov
A SMART Pilot of Adaptive Treatment Strategies to Improve Engagement with a Web-based Smoking Intervention for Socially Anxious Smokers	NIH	National Institute on Drug Abuse	2021	$175,765	July 1, 2020	December 3, 2021	WATSON, NOREEN	reporter.nih.gov
Joint Analysis of Microbiome and Other Genomic Data Types	NIH	National Institute of General Medical Sciences	2021	$175,629	September 1, 2018	March 31, 2022	WU, MICHAEL CHIAO-AN	reporter.nih.gov
Dissecting the Kaposi Sarcoma Tumor Microenvironment at the Single Cell Level	NIH	National Cancer Institute	2021	$175,086	May 9, 2019	March 31, 2022	PHIPPS, WARREN	reporter.nih.gov
Defining BCR evolution during immunization	NIH	National Institute of Allergy and Infectious Diseases	2021	$172,916	December 1, 2012	March 31, 2022	STAMATATOS, LEONIDAS	reporter.nih.gov
Genetic Conflict Shapes Centromeres and Heterochromatin	NIH	National Institute of General Medical Sciences	2021	$170,802	July 1, 2005	March 31, 2022	MALIK, HARMIT S.	reporter.nih.gov
Developing macrophage reprogramming mRNA nanocarriers for initial clinical testing	NIH	National Cancer Institute	2021	$169,133	August 1, 2021	March 31, 2022	STEPHAN, MATTHIAS	reporter.nih.gov
Exploiting WEE1/p53 synthetic lethality as a novel therapy in head and neck cancer	NIH	National Cancer Institute	2021	$166,708	June 14, 2017	March 31, 2022	CLURMAN, BRUCE E	reporter.nih.gov
Preventing Myeloma Relapse after Autologous Stem Cell Transplantation with Decoy Resistant IL-18	NIH	National Cancer Institute	2021	$165,584	March 11, 2021	March 31, 2022	HILL, GEOFFREY ROGER	reporter.nih.gov
The Brain and Maternal Microchimerism	NIH	National Institute of Neurological Disorders and Stroke	2021	$164,829	April 1, 2021	March 31, 2022	NELSON, J. LEE	reporter.nih.gov
Mechanoregulation of Cell Functions during Embryogenesis	NIH	Eunice Kennedy Shriver National Institute of Child Health & Human Development	2021	$163,659	July 20, 2018	March 31, 2022	PARKHURST, SUSAN M	reporter.nih.gov
Optimizing NK Cell-Engaging Bispecific Antibody Therapy Targeting CD33	NIH	National Cancer Institute	2021	$163,219	July 1, 2021	March 31, 2022	WALTER, ROLAND BRUNO	reporter.nih.gov
Identifying relevant HLA-F ligands	NIH	National Institute of Allergy and Infectious Diseases	2021	$159,484	June 1, 2020	March 31, 2022	STRONG, ROLAND K	reporter.nih.gov
Single-Cell Analysis To Define Protective and Tolerizing Immune Cell Populations in the Human Placenta	NIH	National Institute of Allergy and Infectious Diseases	2021	$157,533	February 7, 2020	March 31, 2022	PRLIC, MARTIN	reporter.nih.gov
CAR T-Cell Therapy Targeting the Membrane-Proximal C2-Set Domain of CD33 for Treatment of Acute Myeloid Leukemia and Other CD33-Expressing Hematopoietic Neoplasms	NIH	National Cancer Institute	2021	$157,326	December 10, 2019	March 31, 2022	WALTER, ROLAND BRUNO	reporter.nih.gov
Precision disease prevention via somatic mutagenesis enumeration (PREDICTION)	NIH	National Institute of Environmental Health Sciences	2021	$152,307	September 15, 2018	March 31, 2022	HOLLAND, ERIC C.	reporter.nih.gov
Blood & Marrow Clinical Trials Network- Hutchinson Center as Core Clinical Site	NIH	National Heart, Lung, and Blood Institute	2021	$151,790	June 5, 2002	March 31, 2022	APPELBAUM, FREDERICK	reporter.nih.gov
Integrating health informatics in a scalable stepped care self-management program for survivors after hematopoietic cell transplantation	NIH	National Cancer Institute	2022	$150,296	May 1, 2017	March 31, 2022	BAKER, KEVIN S	reporter.nih.gov
Discovery and Characterization of Capsid-Targeting Lentiviral Restriction Factors	NIH	National Institute of Allergy and Infectious Diseases	2021	$149,405	June 14, 2019	March 31, 2022	OHAINLE, MOLLY	reporter.nih.gov
Translational Epigenomics in Gastrointestinal Cancer	NIH	National Cancer Institute	2021	$147,343	September 19, 2018	March 31, 2022	YU, MING	reporter.nih.gov
Regulation of Chromosome Segregation	NIH	National Institute of General Medical Sciences	2021	$142,234	February 1, 2002	March 31, 2022	BIGGINS, SUSAN	reporter.nih.gov
Developing an intervention to improve follow-up of abnormal fecal immunochemical test results in a safety-net population using a mixed methods approach	NIH	National Cancer Institute	2021	$134,048	September 1, 2019	March 31, 2022	ISSAKA, RACHEL B.	reporter.nih.gov
Peer PrEP referral + HIV self-test for PrEP initiation among young Kenyan women	NIH	National Institute of Mental Health	2021	$132,572	April 1, 2020	March 31, 2022	ORTBLAD, KATRINA FRANCES	reporter.nih.gov
Molecular modeling and machine learning for protein structures and interactions	NIH	National Institute of General Medical Sciences	2021	$131,330	June 1, 2021	March 31, 2022	BRADLEY, PHILIP	reporter.nih.gov
Rational in situ programming of cancer vaccine-responding T-cell clones	NIH	National Cancer Institute	2021	$126,644	July 1, 2021	March 31, 2022	STEPHAN, MATTHIAS	reporter.nih.gov
An AHEI Dietary Intervention to Reduce Pain in Women with Endometriosis	NIH	National Institute of Nursing Research	2021	$121,780	February 11, 2019	March 31, 2022	HARRIS, HOLLY RUTH	reporter.nih.gov
The SyngenicDNA and ÃÂÃÂÃÂÃÂ¼POET Platform: Overcoming Innate Barriers to Genetic Engineering in Bacteria.	NIH	National Institute of Dental & Craniofacial Research	2021	$121,749	September 8, 2017	March 31, 2022	JOHNSTON, CHRISTOPHER D	reporter.nih.gov
Diet and the colonic exfoliome: a novel, non-invasive approach to testing interventions in humans	NIH	National Cancer Institute	2021	$119,129	January 1, 2020	March 31, 2022	LAMPE, JOHANNA W	reporter.nih.gov
Predicting PrEP Uptake and Adherence among Adolescent Girls and Young Women in Sub-Saharan Africa: Leveraging Programmatic and Clinical Trials Data	NIH	Eunice Kennedy Shriver National Institute of Child Health & Human Development	2021	$118,787	August 1, 2017	March 31, 2022	DUERR, ANN C	reporter.nih.gov
Targeted disruption of the YAP/TAZ/TEAD axis in pancreatic cancer	NIH	National Cancer Institute	2021	$110,651	September 1, 2021	March 31, 2022	NABET, BEHNAM	reporter.nih.gov
Development and Feasibility Testing of a Multi-Component Intervention to Increase HIV Testing and Linkage to Services among MSM in Peru	NIH	National Institute of Mental Health	2021	$106,664	July 15, 2021	March 31, 2022	LANKOWSKI, ALEXANDER JULIAN	reporter.nih.gov
Optimization of Siglec-8-Directed Immunotherapy for Eosinophilic and Mast Cell Disorders	NIH	National Institute of Allergy and Infectious Diseases	2021	$106,142	April 1, 2020	March 31, 2022	WALTER, ROLAND BRUNO	reporter.nih.gov
Targeting the DNA Damage Response in HPV+ Head and Neck Cancer	NIH	National Institute of Dental & Craniofacial Research	2021	$106,128	July 1, 2021	March 31, 2022	DIAB, AHMED MOHAMED	reporter.nih.gov
Longitudinal Impact of Respiratory Viruses on Bronchiolitis Obliterans Syndrome in Allogeneic Hematopoietic Cell Transplant Recipients	NIH	National Heart, Lung, and Blood Institute	2022	$100,633	December 1, 2021	March 31, 2022	CHENG, GUANG-SHING	reporter.nih.gov
Genetic Innovation of Cytoskeletal Proteins for Specialized Functions in the Male Germline	NIH	National Institute of General Medical Sciences	2021	$100,000	April 1, 2020	October 31, 2021	SCHROEDER, COURTNEY MEGAN	reporter.nih.gov
Genome-wide mechanisms and dynamics of ATP-dependent chromatin remodeling complexes	NIH	National Institute of General Medical Sciences	2021	$99,999	April 1, 2021	March 31, 2022	BRAHMA, SANDIPAN	reporter.nih.gov
Molecular impediments to fate-specifying pioneer factor activity during development	NIH	National Institute of General Medical Sciences	2021	$97,999	March 3, 2021	March 31, 2022	MEERS, MICHAEL P	reporter.nih.gov
Telephone Delivered Acceptance & Commitment Therapy for Weight Loss	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021	$97,327	July 1, 2020	March 31, 2022	BRICKER, JONATHAN B	reporter.nih.gov
Prospectively characterizing the functional and antigenic effects of mutations to viral entry proteins	NIH	National Institute of Allergy and Infectious Diseases	2021	$95,883	September 24, 2018	March 31, 2022	BLOOM, JESSE D	reporter.nih.gov
Air pollution and health disparities in liver disease and cancer	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021	$95,025	July 15, 2020	March 31, 2022	VOPHAM, TRANG	reporter.nih.gov
Quantifying the genetic and environmental factors driving avian influenza spillover	NIH	National Institute of Allergy and Infectious Diseases	2021	$95,010	July 6, 2020	March 31, 2022	MONCLA, LOUISE HILLIER	reporter.nih.gov
Functional and transcriptional analysis of embryonic hematopoietic stem cell development at the single cell level	NIH	National Heart, Lung, and Blood Institute	2021	$92,910	January 8, 2018	December 31, 2021	HADLAND, BRANDON K	reporter.nih.gov
An mHealth mood management tool to improve population-level tobacco cessation	NIH	National Institute on Drug Abuse	2021	$90,494	August 1, 2020	March 31, 2022	HEFFNER, JAIMEE	reporter.nih.gov
HLA at the Interface of Self and Other During Pregnancy	NIH	National Institute of Allergy and Infectious Diseases	2021	$88,000	April 14, 2021	March 31, 2022	NELSON, J. LEE	reporter.nih.gov
Defining and targeting mechanisms of pancreas cancer pathogenesis	NIH	National Cancer Institute	2021	$77,889	September 19, 2017	March 31, 2022	WHITTLE, MARTIN	reporter.nih.gov
Novel synthetic receptors with improved antigen specificity and specificity for cancer therapy	NIH	National Cancer Institute	2022	$75,386	April 1, 2005	March 31, 2022	RIDDELL, STANLEY R.	reporter.nih.gov
Annual HVTN Translational HIV Early Stage Investigator (ESI) Conference	NIH	Office of the Director, National Institutes of Health	2021	$74,999	April 7, 2017	March 31, 2022	KUBLIN, JAMES G.	reporter.nih.gov
Statistical Methods for Evaluating Markers for Treatment Selection	NIH	National Cancer Institute	2021	$71,331	July 1, 2010	March 31, 2022	JANES, HOLLY	reporter.nih.gov
Spatiotemporal mechanisms of in vivo axon initiation and targeting during development	NIH	Eunice Kennedy Shriver National Institute of Child Health & Human Development	2021	$70,197	May 4, 2021	December 14, 2021	ISABELLA, ADAM JAMES	reporter.nih.gov
Advanced statistical modeling and analytics for prostate cancer interventions	NIH	National Cancer Institute	2021	$66,904	September 20, 2017	March 31, 2022	GULATI, ROMAN	reporter.nih.gov
Autoantibody-based early detection of small-cell lung cancer by immunoimaging	NIH	National Cancer Institute	2021	$62,084	April 1, 2021	March 4, 2022	KUNIHIRO, ANDREW GEORGE KENRO	reporter.nih.gov
Elucidating the mechanisms of kinetochore assembly initiation	NIH	National Institute of General Medical Sciences	2021	$61,229	May 1, 2020	March 31, 2022	POPCHOCK, ANDREW R	reporter.nih.gov
Simulating persistence and elimination of the HIV reservoir	NIH	National Institute of Allergy and Infectious Diseases	2021	$58,852	August 1, 2020	March 31, 2022	REEVES, DANIEL	reporter.nih.gov
Modeling to Minimize Detection Bias in Cancer Risk Prediction Studies	NIH	National Cancer Institute	2021	$58,589	September 19, 2019	March 31, 2022	ETZIONI, RUTH D	reporter.nih.gov
Anti-CD38 targeted alpha emitter radioimmunotherapy to eliminate multiple myeloma	NIH	National Cancer Institute	2022	$56,218	March 8, 2017	March 31, 2022	GREEN, DAMIAN J.	reporter.nih.gov
Evolutionary dynamics of antibody affinity maturation	NIH	National Institute of Allergy and Infectious Diseases	2021 to 2022	$50,063	January 1, 2020	March 31, 2022	DEWITT, WILLIAM S.	reporter.nih.gov
Elucidating the role of somatic 3’UTR mutations in prostate cancer pathogenesis	NIH	National Cancer Institute	2021 to 2022	$49,374	March 1, 2021	March 31, 2022	SCHUSTER, SAMANTHA LEE	reporter.nih.gov
Predicting transcriptional signatures and tumor subtypes from circulating tumor DNA	NIH	National Cancer Institute	2021	$44,945	September 10, 2021	March 31, 2022	HA, GAVIN	reporter.nih.gov
Investigating the Role of DNA Repair Mutations in Prostate Cancer Initiation, Progression, and Susceptibility to Targeted Therapies	NIH	National Cancer Institute	2021	$44,369	August 1, 2019	March 31, 2022	FRANK, SANDER BARKLEY	reporter.nih.gov
Biology and therapy of C11orf95-RELA fusion-driven ependymoma	NIH	National Cancer Institute	2021	$41,230	September 1, 2021	March 31, 2022	HOLLAND, ERIC C.	reporter.nih.gov
Forecasting influenza evolution on a heterogeneous immune landscape	NIH	National Institute of Allergy and Infectious Diseases	2022	$35,200	February 15, 2022	March 31, 2022	BEDFORD, TREVOR BC	reporter.nih.gov
Career Development in Pediatric and Medical Oncology	NIH	National Cancer Institute	2021	$34,305	September 30, 1997	March 31, 2022	MESHINCHI, SOHEIL	reporter.nih.gov
Mechanisms of Target-Specific Axon Regeneration	NIH	National Institute of Neurological Disorders and Stroke	2022	$33,537	December 15, 2021	March 31, 2022	ISABELLA, ADAM JAMES	reporter.nih.gov
Mechanisms and consequences of cytoskeletal control of Helicobacter pylori cell shape	NIH	National Institute of Allergy and Infectious Diseases	2021	$31,902	August 1, 2020	March 31, 2022	SICHEL, SOPHIE R.	reporter.nih.gov
Cytomegalovirus-specific Immune Reconstitution after Hematopoietic Cell Transplantation in the Era of Modern Antiviral Prophylaxis	NIH	National Institute of Allergy and Infectious Diseases	2022	$31,571	February 7, 2022	March 31, 2022	ZAMORA, DANNIEL	reporter.nih.gov
Discovery of sensorimotor connectivity mechanisms in a continuous topographic map	NIH	National Institute of Neurological Disorders and Stroke	2022	$28,276	February 1, 2022	March 31, 2022	MOENS, CECILIA B	reporter.nih.gov
Reactivation of an early embryonic program in FSHD and cancer	NIH	National Cancer Institute	2022	$23,676	December 1, 2020	March 31, 2022	HAMM, DANIELLE	reporter.nih.gov
Molecular mechanisms underlying neuronal integrity	NIH	National Institute of Neurological Disorders and Stroke	2022	$13,411	January 1, 2021	March 31, 2022	JIMENEZ, MONET A.	reporter.nih.gov
Profiling and leveraging bystander T cells within the tumor microenvironment	NIH	National Cancer Institute	2021	$13,235	September 1, 2021	December 31, 2021	MAURICE, NICHOLAS JOSEPH	reporter.nih.gov
Immunogenetic determinants of HSV-2 infection and disease	NIH	National Institute of Allergy and Infectious Diseases	2021	$11,671	June 1, 2020	March 31, 2022	LUND, JENNIFER M	reporter.nih.gov
The impact of HIV on the breast cancer tumor microenvironment	NIH	Fogarty International Center	2021	$10,268	August 16, 2021	March 31, 2022	MENON, MANOJ P	reporter.nih.gov
5th Workshop on Viral Dynamics	NIH	National Institute of Allergy and Infectious Diseases	2021	$9,000	July 8, 2021	March 31, 2022	SCHIFFER, JOSHUA TISDELL	reporter.nih.gov
Necrosis-mediated circulating tumor cell dissemination	NIH	National Cancer Institute	2022	$2,601	March 1, 2022	March 31, 2022	YAMAMOTO, AMI	reporter.nih.gov
Interdisciplinary Epidemiologic Consortium to Investigate T-cell Response in Colorectal Cancer	NIH	National Cancer Institute	2021	$1	May 1, 2020	March 31, 2022	PETERS, ULRIKE	reporter.nih.gov
Blending deep learning with probabilistic mechanistic models to predict and understand the evolution and function of adaptive immune receptors	NIH	National Institute of Allergy and Infectious Diseases	2021	$1	June 1, 2019	March 31, 2022	MATSEN, FREDERICK ALBERT	reporter.nih.gov
Development of 211Astatine-Conjugated Anti-CD45 Antibody-Based Conditioning for Hematopoietic Stem Cell Gene Therapy and Editing	NIH	National Heart, Lung, and Blood Institute	2021	$1	May 15, 2020	March 31, 2022	WALTER, ROLAND BRUNO	reporter.nih.gov
Identification of Novel Mucosal Immune Mechanisms Involved in Protection from HIV-1	NIH	National Institute of Allergy and Infectious Diseases	2021	$1	June 8, 2017	March 31, 2022	LUND, JENNIFER M	reporter.nih.gov
Mechanisms and consequence of helical shape generation in Helicobacter pylori	NIH	National Institute of Allergy and Infectious Diseases	2021	$1	June 1, 2018	March 31, 2022	SALAMA, NINA	reporter.nih.gov
Combining Targeted RIT and Synergistic Novel Agents to Eradicate AML	NIH	National Cancer Institute	2021	$1	June 1, 2020	March 31, 2022	OROZCO, JOHNNIE JOSE	reporter.nih.gov
Advancing equity in colorectal cancer genetic risk prediction through expansion of racial/ethnic minority representation	NIH	National Cancer Institute	2021	$1	July 1, 2020	March 31, 2022	PETERS, ULRIKE	reporter.nih.gov
Statistical Methods for Prospective Evaluation of Biomarkers	NIH	National Cancer Institute	2021	$1	September 4, 2009	March 31, 2022	ZHENG, YINGYE	reporter.nih.gov
Molecular pathoepidemiology of contralateral breast cancer	NIH	National Cancer Institute	2021	$1	March 1, 2017	March 31, 2022	MALONE, KATHLEEN E	reporter.nih.gov
Clinical translation of a NexGen platform for quantifying protein networks in human biospecimens	NIH	National Cancer Institute	2021	$1	July 1, 2019	March 31, 2022	PAULOVICH, AMANDA G	reporter.nih.gov
Methods for Analyzing Cancer Somatic Mutation Data	NIH	National Cancer Institute	2021	$1	September 20, 2018	March 31, 2022	HE, QIANCHUAN	reporter.nih.gov
Life and Longevity After Cancer (LILAC): The Women's Health Initiative Cancer Survivor Cohort	NIH	National Cancer Institute	2021	$1	February 15, 2013	March 31, 2022	ANDERSON, GARNET L.	reporter.nih.gov
Characterizing determinants of primary KSHV infection among children and adolescents in Uganda	NIH	National Cancer Institute	2021	$1	September 13, 2019	March 31, 2022	PHIPPS, WARREN	reporter.nih.gov
Training Program in Infectious Diseases in the Immunocompromised Host	NIH	National Institute of Allergy and Infectious Diseases	2021	$1	August 1, 2016	March 31, 2022	BOECKH, MICHAEL J	reporter.nih.gov
Flow Cytometry Training Workshop 2021-22	NIH	National Institute of Allergy and Infectious Diseases	2021	$1	August 6, 2021	March 31, 2022	ANDERSEN-NISSEN, ERICA	reporter.nih.gov
Type II diabetes, related biomarkers and medications, and ovarian cancer risk	NIH	National Cancer Institute	2022	$1	February 1, 2022	March 31, 2022	HARRIS, HOLLY RUTH	reporter.nih.gov
Defining the role of C. elegans Parkin/PDR-1 in glial engulfment of neuron fragments	NIH	National Institute of Neurological Disorders and Stroke	2022	$1	March 1, 2021	March 31, 2022	RAIDERS, STEPHAN	reporter.nih.gov
Integrating T cell receptor features with gene expression profiles to define T cell specificity and differentiation	NIH	National Institute of Allergy and Infectious Diseases	2022	$1	February 8, 2022	March 31, 2022	BRADLEY, PHILIP	reporter.nih.gov

Funding by fiscal year

Fiscal year	NIH awards	NIH amount	NSF awards	NSF amount
2022	55	$44,774,762	0	$0
2021	243	$409,329,615	0	$0

Open federal funding opportunities

From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.

Open opportunity	Number	Agency	Listing	Closes	Award ceiling	Why it matches
Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required)	RFA-AI-27-002	NIH	93.855	November 10, 2026	Not listed	Same assistance listing 93.855 as 50 awards here
Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required)	RFA-AI-27-005	NIH	93.855	November 10, 2026	Not listed	Same assistance listing 93.855 as 50 awards here
Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)	PAR-25-370	NIH	93.855	November 16, 2026	$50,000	Same assistance listing 93.855 as 50 awards here
Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)	PAR-25-369	NIH	93.855	November 18, 2026	Not listed	Same assistance listing 93.855 as 50 awards here
Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)	PAR-25-371	NIH	93.855	November 18, 2026	Not listed	Same assistance listing 93.855 as 50 awards here
Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)	PAR-25-379	NIH	93.855	January 7, 2027	Not listed	Same assistance listing 93.855 as 50 awards here
HIV/AIDS Clinical Trials Network Leadership and Operations Centers	RFA-AI-28-001	NIH	93.855	January 22, 2027	Not listed	Same assistance listing 93.855 as 50 awards here
HIV/AIDS Clinical Trials Network Laboratory Centers	RFA-AI-28-002	NIH	93.855	January 22, 2027	Not listed	Same assistance listing 93.855 as 50 awards here
HIV/AIDS Clinical Trials Network Statistical and Data Management Centers	RFA-AI-28-003	NIH	93.855	January 22, 2027	Not listed	Same assistance listing 93.855 as 50 awards here
HIV/AIDS Clinical Trials Network Clinical Trials Units	RFA-AI-28-004	NIH	93.855	January 22, 2027	Not listed	Same assistance listing 93.855 as 50 awards here
Precision and Systems Biology to Uncover the Link Between Chronic and Infectious Diseases	RFA-AI-28-014	NIH	93.855	January 22, 2027	Not listed	Same assistance listing 93.855 as 50 awards here
Immune Tolerance Network (UM1 Clinical Trial Required)	RFA-AI-28-005	NIH	93.855	January 29, 2027	Not listed	Same assistance listing 93.855 as 50 awards here
Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed)	RFA-AI-28-012	NIH	93.855	January 29, 2027	Not listed	Same assistance listing 93.855 as 50 awards here
Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed)	RFA-AI-28-024	NIH	93.855	February 11, 2027	Not listed	Same assistance listing 93.855 as 50 awards here
NLM Institutional Grants for Research Training in Biomedical Informatics, Data Science, and AI (T15 Independent Clinical Trial Not Allowed)	RFA-LM-28-001	NIH	93.855	February 11, 2027	$775,000	Same assistance listing 93.855 as 50 awards here
NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)	PA-27-100	NIH	93.855	April 5, 2027	Not listed	Same assistance listing 93.855 as 50 awards here
NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)	PA-27-102	NIH	93.855	April 5, 2027	Not listed	Same assistance listing 93.855 as 50 awards here
Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed)	PA-24-176	NIH	93.855	May 7, 2027	Not listed	Same assistance listing 93.855 as 50 awards here
Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Not Allowed)	PA-24-185	NIH	93.855	May 7, 2027	Not listed	Same assistance listing 93.855 as 50 awards here
Midcareer Investigator Award in Patient-Oriented Research (Parent K24 Independent Clinical Trial Required)	PA-24-187	NIH	93.855	May 7, 2027	Not listed	Same assistance listing 93.855 as 50 awards here

Topics of its NIH awards

Updated November 4, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-04). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.